Results 211 to 220 of about 249,813 (313)

Successful treatment of eosinophilic esophagitis with upadacitinib prescribed for atopic dermatitis

JPGN Reports, EarlyView.
Abstract We describe a pediatric patient treated with upadacitinib for atopic dermatitis (AD) who subsequently achieved sustained clinical and histologic remission of eosinophilic esophagitis (EoE). Upadacitinib is an oral small molecule selective Janus kinase 1 inhibitor that inhibits janus kinase‐signal transduction and activation of transcription ...
Nathalie Nguyen, Maureen Bauer
wiley   +1 more source

The safe and effective use of tofacitinib and ustekinumab combination therapy in infantile onset inflammatory bowel disease

JPGN Reports, EarlyView.
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan, Christian Wysocki, Bhaskar Gurram   +2 more
wiley   +1 more source

Longitudinal Effectiveness of Repeated Lifestyle Education in Pediatric Dyslipidemia: Developmental and Environmental Modifiers in a Real-World Clinical Cohort. [PDF]

Children (Basel)
Min SY, Kim EY.
europepmc   +1 more source

Epidemiological characteristics of serum small dense low-density lipoprotein cholesterol: From 2017 to 2019 in Chengdu adults, China. [PDF]

Medicine (Baltimore)
Li J, Lv Z, He E, Wang H, Wu L, Wei Y, Quan H, Zhang S.   +7 more
europepmc   +1 more source

A Cross‐Sectional Survey Study Assessing the Quality of Life and Sleep in Spanish Psoriasis Patients

JEADV Clinical Practice, EarlyView.
Psoriasis impacts quality of life (QOL) and sleep (QOS), yet dermatology assessments often do not evaluate sleep. The Short‐form health survey (SF‐36) and Pittsburg sleep quality index (PSQI) further investigated patients’ QOL and QOS. Particularly women, unemployed patients, and those that use sleep medications had worse QOS and QOL.
Gabriela Piñero‐Crespo, María Isabel del Pino Rincón, Lilia Correa‐Selm, Raquel Hernández Sánchez, Amalia Pérez‐Gil   +4 more
wiley   +1 more source

Novel Therapies, Residual Risk, Familial Hypercholesterolemia, and Digital Tools: Multispecialty Insights from a Dyslipidemia Management Survey. [PDF]

J Clin Med
Mesquita-Lousada A, Rocha-Melo-Sousa A, Teixeira C, Guimarães TR, Marques-Vieira M, Andrade JP, Ribeiro H, Neiva-Sousa M, Rocha-Neves J.   +8 more
europepmc   +1 more source

Risk and dyslipidemia

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2018
openaire   +3 more sources

Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review

JEADV Clinical Practice, EarlyView.
This systematic review identifies consistent clinical patterns of alopecia areata associated with IL‐17 and IL‐23 inhibitors, most frequently involving secukinumab and ustekinumab. Disease severity varied widely, and management often required biologic discontinuation or therapeutic switching.
Isabella Kamholtz, Simonetta I. Gaumond, Joaquin J. Jimenez   +2 more
wiley   +1 more source